Homeopathic Drug Standardization

Jahangir Satti PhD
{"title":"Homeopathic Drug Standardization","authors":"Jahangir Satti PhD","doi":"10.1016/j.sigm.2006.04.001","DOIUrl":null,"url":null,"abstract":"<div><p>Advancements in scientific techniques have enabled researchers to critically examine and scrutinize nonconventional therapies to either validate or reject them for routine clinical practice. The substantiation of the homeopathic system has been controversial since there is no standard drug dilution strength that can be subjected to clinical tests. Homeopaths usually claim to achieve curative effects by using homeopathic substances ranging in concentration from mother tinctures in crude forms to infinitesimal dilutions with a probability of almost zero active ingredients in them. The issue becomes further confused when different criteria are applied to drug dilution preparations that are inconsistent with any established scientific metric such as Avogadro’s number. This fact was well known to its founder, Dr. Hahnemann, who tried to establish drug standardization around the 30th dilution during his last years of life. He even developed a semi-nonlinear method, known as LM potencies, which was revealed in his postmortem publication of <em>Organon of Medicine</em>, 6th edition, in 1921. Dr. Hering, founder of American Homeopathy, devised the decimal dilution method, which, like the earlier dilution methods, lacked any fundamental metric such as Avogadro’s number. A literature search revealed that the drug dilution and standardization issues were never settled in homeopathy. The issues of miracle cures with different dilutions become questionable when such claims are examined in the absence of any placebo or control studies. In short, homeopathy has failed to establish validity of its dilutions’ effects in general research settings. The common denominator to all such failures can be attributed to the absence of standardization of drug dilutions based on scientific metrics. Different drugs are composed of different numbers of atoms/molecules to start with. A single linear no-threshold method cannot standardize the heterogeneous drugs to a desired unique scale. A nonlinear method is needed to standardize homeopathic drugs to a single scale such as the 30th to either validate or reject them on scientific grounds. This issue becomes more important in the light of new emerging nanotechnology. Homeopathic drug standardization based on scientific metrics is needed for research and reproducibility for routine clinical practice.</p></div>","PeriodicalId":101156,"journal":{"name":"Seminars in Integrative Medicine","volume":"3 4","pages":"Pages 113-122"},"PeriodicalIF":0.0000,"publicationDate":"2005-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.sigm.2006.04.001","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Integrative Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1543115006000056","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

Advancements in scientific techniques have enabled researchers to critically examine and scrutinize nonconventional therapies to either validate or reject them for routine clinical practice. The substantiation of the homeopathic system has been controversial since there is no standard drug dilution strength that can be subjected to clinical tests. Homeopaths usually claim to achieve curative effects by using homeopathic substances ranging in concentration from mother tinctures in crude forms to infinitesimal dilutions with a probability of almost zero active ingredients in them. The issue becomes further confused when different criteria are applied to drug dilution preparations that are inconsistent with any established scientific metric such as Avogadro’s number. This fact was well known to its founder, Dr. Hahnemann, who tried to establish drug standardization around the 30th dilution during his last years of life. He even developed a semi-nonlinear method, known as LM potencies, which was revealed in his postmortem publication of Organon of Medicine, 6th edition, in 1921. Dr. Hering, founder of American Homeopathy, devised the decimal dilution method, which, like the earlier dilution methods, lacked any fundamental metric such as Avogadro’s number. A literature search revealed that the drug dilution and standardization issues were never settled in homeopathy. The issues of miracle cures with different dilutions become questionable when such claims are examined in the absence of any placebo or control studies. In short, homeopathy has failed to establish validity of its dilutions’ effects in general research settings. The common denominator to all such failures can be attributed to the absence of standardization of drug dilutions based on scientific metrics. Different drugs are composed of different numbers of atoms/molecules to start with. A single linear no-threshold method cannot standardize the heterogeneous drugs to a desired unique scale. A nonlinear method is needed to standardize homeopathic drugs to a single scale such as the 30th to either validate or reject them on scientific grounds. This issue becomes more important in the light of new emerging nanotechnology. Homeopathic drug standardization based on scientific metrics is needed for research and reproducibility for routine clinical practice.

顺势疗法药物标准化
科学技术的进步使研究人员能够严格检查和审查非常规疗法,以验证或拒绝常规临床实践。顺势疗法系统的证实一直存在争议,因为没有标准的药物稀释强度可以进行临床试验。顺势疗法医生通常声称通过使用顺势疗法物质来达到疗效,其浓度从原始形式的母体酊剂到极少量的稀释剂,其中几乎没有活性成分的可能性。当不同的标准应用于与任何既定科学度量(如阿伏伽德罗数)不一致的药物稀释制剂时,问题变得更加混乱。它的创始人哈内曼博士很清楚这一点,他在生命的最后几年里试图在30倍稀释度左右建立药物标准化。他甚至发明了一种半非线性的方法,被称为LM效力,并在1921年出版的《医学原理》第六版中发表。赫林博士是美国顺势疗法的创始人,他发明了十进制稀释法,和早期的稀释法一样,这种方法没有任何基本的度量,比如阿伏伽德罗数。文献检索显示,顺势疗法的药物稀释和标准化问题从未得到解决。在没有任何安慰剂或对照研究的情况下,对不同稀释度的奇迹般的治疗方法进行检验时,问题就变得值得怀疑了。简而言之,顺势疗法未能在一般研究环境中建立其稀释效果的有效性。所有这些失败的共同点可归因于缺乏基于科学指标的药物稀释度标准化。不同的药物是由不同数量的原子/分子组成的。单一的线性无阈值方法无法将异质性药物标准化到所需的唯一标度。需要一种非线性的方法来将顺势疗法药物标准化到单一的尺度,比如第30个尺度,从而在科学的基础上验证或拒绝它们。鉴于新兴的纳米技术,这个问题变得更加重要。顺势疗法药物标准化需要建立在科学指标的基础上,以促进常规临床实践的研究和可重复性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信